- The Role of Circulating Biomarkers in the Oncological Management of Metastatic Renal Cell Carcinoma: Where Do We Stand Now?
Alessandra Cinque et al, 2021, Biomedicines CrossRef - Current Trends in Liquid Biopsy Technology for Early Diagnosis of Metastatic Renal Cell Carcinoma
Jeong Yoon Suh et al, 2022, The Korean Journal of Urological Oncology CrossRef - TRAIL-R3/R4 and Inhibition of TRAIL Signalling in Cancer
Lubna Danish et al, 2017, TRAIL, Fas Ligand, TNF and TLR3 in Cancer CrossRef - Liquid Biopsies in Renal Cell Carcinoma—Recent Advances and Promising New Technologies for the Early Detection of Metastatic Disease
Harini Lakshminarayanan et al, 2020, Frontiers in Oncology CrossRef - Serum and Urine Biomarkers for Human Renal Cell Carcinoma
A. L. Pastore et al, 2015, Disease Markers CrossRef - Renal tumor biomarkers (Review)
Ovidiu Bratu et al, 2021, Experimental and Therapeutic Medicine CrossRef - Effect of trail C1595T variant and gene expression on the pathogenesis of non-small cell lung cancer
Öncü Koç Erbaşoğlu et al, 2019, Libyan Journal of Medicine CrossRef - Epigallocatechin-3-gallate Sensitizes Human 786-O Renal Cell Carcinoma Cells to TRAIL-Induced Apoptosis
Ruojing Wei et al, 2015, Cell Biochemistry and Biophysics CrossRef - Circulating nuclear factor-kappa B mediates cancer-associated inflammation in human breast and colon cancer
Kundaktepe Papila et al, 2021, Journal of Medical Biochemistry CrossRef - The Neutrophil: The Underdog That Packs a Punch in the Fight against Cancer
Natasha Ustyanovska Avtenyuk et al, 2020, International Journal of Molecular Sciences CrossRef - Tumour necrosis factor‐related apoptosis‐inducing ligand (TRAIL) loss in canine mammary carcinoma
Soo‐Hyeon Kim et al, 2022, Veterinary and Comparative Oncology CrossRef